About me
Rachel Ellingson was appointed Senior Vice President, Chief Administrative Officer in June 2024. In her role, she is responsible for strategy, business development (M&A execution and integration, strategic partnerships, divestitures and minority investments), marketing and communications, as well as the Office of the CEO. Ms. Ellingson joined Zimmer Biomet in April 2018 as Senior Vice President, Chief Strategy Officer.
Prior to joining the Company, Ms. Ellingson served as Vice President, Corporate Strategy and as a member of the executive leadership team at St. Jude Medical. Before joining St. Jude Medical, she served as Vice President, Business Development and Investor Relations at AGA Medical Corporation.
Earlier in her career, Ms. Ellingson spent 15 years as an investment banker focused primarily on the medical technology sector with several investment banks, including Bank of America and Cowen & Company.
She has served as a member of the board of directors of BioLife Solutions, Inc. since April 2021, serving on their Audit Committee and Compensation Committee.
Ms. Ellingson holds a Bachelor of Arts degree from the University of Rhode Island and a Master of Business Administration in Finance from the University of Connecticut.
